Biovail agrees to $24.6M settlement for kickbacks
Pharma Compliance Alert, May 28, 2008
Illegal kickbacks used to induce physicians to prescribe Cardizem LA will cost Biovail Pharmaceuticals $24.6 million, according to a Department of Justice press release.
Beginning in 2003, Biovail used the Proving Long Acting Through Experience, or PLACE program, to accelerate the use of Cardizem LA.
Physicians and other medical professionals were paid $250 to enroll in the program and complete a two-page multiple choice questionnaire. If the prescriber returned the final questionnaire, he or she would be paid an additional:
- $250 for enrolling between one and five patients
- $500 for enrolling between six and 10 patients
- $750 for enrolling between 11 and 15 patients
Comments
0 comments on “Biovail agrees to $24.6M settlement for kickbacks ”
Related Products
-
ePharm5 InDepth
EPharm5 e-mail newsletter delivers the top 5 developments in pharma business innovation, with original research, interviews...
-
Big Pharma Performance Before, During and Beyond the Global Recession
This report assesses the performance of the leading 15 pharmaceutical companies up to, during and beyond the recent global...
Most Popular
- Articles
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Catch up on what's new with injections and infusions
- Topic: CMS, OESS post new security compliance review information, checklist
- What does case-mix index mean to you?
- QA:Coding multiple initial infusions
- Capturing all necessary codes for IUD insertion and removal can be challenging
- News and briefs: Oklahoma Osteopathic Association against residency bill change
- OB services: Coding inside and outside of the package
- HIPAA Q&A: Level of encryption needed for email
- E-mailed
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Catch up on what's new with injections and infusions
- New conflicts of interest create new challenges
- What does case-mix index mean to you?
- Joint Commission Center announces handoff communication solutions
- Inside best practice: Reduce patient falls with a stoplight
- Identify modifiable risk factors to prevent patient falls
- Hospitalist-surgeon comanagement has no effect on outcomes
- HIPAA Q&A: Level of encryption needed for email
- Searched